Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inventurus Knowledge SolutionsNSE:IKS -2.42%23 Debt-to-EBITDA is 0.00 as of Jun. 2026. GuruFocus rates NSE:IKS with a GF Score™ of 23/100. The stock has 1 warning sign investors should review. Among 480 Healthcare Providers & Services companies, Inventurus Knowledge Solutions ranks better than 77.71% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Inventurus Knowledge Solutions's Debt-to-EBITDA or its related term are showing as below:
NSE:IKS'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.13 Med: 0.69 Max: 2.35
Current: 0.65
During the past 5 years, the highest Debt-to-EBITDA Ratio of Inventurus Knowledge Solutions was 2.35. The lowest was 0.13. And the median was 0.69.
NSE:IKS's Debt-to-EBITDA is ranked better than 77.71% of 480
companies
in the Healthcare Providers & Services industry
Industry Median: 2.185
vs NSE:IKS: 0.65
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Inventurus Knowledge Solutions Debt-to-EBITDA Related Terms
Inventurus Knowledge Solutions Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:IKS vs VEEV, BTSG, TEM: Debt-to-EBITDA Comparison
For the Health Information Services subindustry, Inventurus Knowledge Solutions's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inventurus Knowledge Solutions Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Inventurus Knowledge Solutions's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Inventurus Knowledge Solutions's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Inventurus Knowledge Solutions (NSE:IKS) has a Debt-to-EBITDA of 0.00 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Inventurus Knowledge Solutions. Over the past decade, Inventurus Knowledge Solutions' Debt-to-EBITDA has ranged from 0.13 to 2.35. According to the industry distribution chart, Inventurus Knowledge Solutions ranks #107 out of 480 companies in the Healthcare Providers & Services industry, placing it in the top 22.3%.
Is Inventurus Knowledge Solutions' Debt-to-EBITDA too high?
Inventurus Knowledge Solutions' current Debt-to-EBITDA is 0.00. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 2.35. Based on the distribution chart, Inventurus Knowledge Solutions ranks #107 out of 480 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Inventurus Knowledge Solutions has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Inventurus Knowledge Solutions' Debt-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Inventurus Knowledge Solutions ranks #107 out of 480 companies for Debt-to-EBITDA. This places Inventurus Knowledge Solutions in the top 22% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.19. Historically, Inventurus Knowledge Solutions' own Debt-to-EBITDA has ranged from 0.13 to 2.35 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Inventurus Knowledge Solutions. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inventurus Knowledge Solutions's current Debt-to-EBITDA is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inventurus Knowledge Solutions stock overvalued right now?
Inventurus Knowledge Solutions (NSE:IKS) has a current Debt-to-EBITDA of 0.00. The current Debt-to-EBITDA is 0.00. Inventurus Knowledge Solutions' overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Inventurus Knowledge Solutions (NSE:IKS), the current Debt-to-EBITDA is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Inventurus Knowledge Solutions Ltd is a technology enabled healthcare solutions provider, serving the U.S healthcare market. The group offer a comprehensive care enablement platform that supports healthcare enterprises across outpatient and inpatient care settings. It is operates in in Care Enablement, empowering healthcare organizations to deliver high-quality care efficiently and sustainably through an integrated platform that combines technology and deep human expertise. The Company operates in one reportable segment which is Healthcare. Its solutions are Revenue Cycle Management, Clinical Support, and Value-Based Care.
23GF Score
Get the complete analysis for NSE:IKS
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:IKS has been successfully added to your 
